Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2026-01-25 @ 12:34 PM
Study NCT ID:
NCT05493995
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2022-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Neoplasms | View |
Keywords: